Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewMasitinib is a potent inhibitor of the tyrosine kinase receptor colony-stimulating factor 1R (CSF-1R) (IC50 = 90 nM). It is also an NLRP3 inflammasome activator. Masitinib additionally inhibits the proteolytic activity of SARS-CoV-2 main protease (Mpro) and blocks viral replication, as well as acting as a PDGFRα/β inhibitor. In vivo, Masitinib ameliorates cognitive impairment in transgenic mice model of Alzheimer's disease, and slows disease progression in a rat model of amyotrophic lateral sclerosis (ALS). Orally bioavailable.
分子量 | 498.64 |
公式 | C28H30N6OS |
储存 | Store at -20°C |
纯度 | ≥98% (HPLC) |
CAS Number | 790299-79-5 |
PubChem ID | 10074640 |
InChI Key | WJEOLQLKVOPQFV-UHFFFAOYSA-N |
Smiles | O=C(NC1=CC=C(C(=C1)NC2=NC(=CS2)C=3C=NC=CC3)C)C4=CC=C(C=C4)CN5CCN(C)CC5 |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
溶剂 | 最高浓度 mg/mL | 最高浓度 mM | |
---|---|---|---|
溶解性 | |||
DMSO | 49.86 | 100 | |
ethanol | 4.99 | 10 |
以下数据基于产品分子量 498.64。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
浓度/溶剂体积/质量 | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.01 mL | 10.03 mL | 20.05 mL |
5 mM | 0.4 mL | 2.01 mL | 4.01 mL |
10 mM | 0.2 mL | 1 mL | 2.01 mL |
50 mM | 0.04 mL | 0.2 mL | 0.4 mL |
参考文献是支持产品生物活性的出版物。
Martínez-Ortega et al (2021) In silico characterization of Masitinib interaction with SARS-CoV-2 main protease. ChemMedChem. 16 2339 PMID: 34142459
Li et al (2020) Effects of chronic Masitinib treatment in APPswe/PSEN1dE9 transgenic mice modeling Alzheimer's disease. J.Alzheimers.Dis. 76 1339 PMID: 32623401
Trias et al (2016) Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis. J.Neuroinflammation 13 177 PMID: 27400786
Ettcheto et al (2021) Masitinib for the treatment of Alzheimer's disease. Neurodegener.Dis.Manag. 11 263 PMID: 34412534
Drayman et al (2021) Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2. Science 373 931 PMID: 34285133
If you know of a relevant reference for Masitinib, please let us know.
关键词: Masitinib, Masitinib supplier, potent, CSF-1R, NLRP3, inflammasome, activator, SARS-CoV-2, Mpro, Alzheimer, disease, AD, amyotrophic, lateral, sclerosis, ALS, orally, bioavailable, in, vivo, PDGFR, Other, RTKs, Inflammasomes, 3C, and, 3CL, Proteases, Coronavirus, 7705, Tocris Bioscience
引用文献是使用了 Tocris 产品的出版物。
目前没有 Masitinib 的引用文献。 您是否知道使用了 Tocris Masitinib 的优秀论文? 请告知我们.
目前没有该产品的评论。 Be the first to review Masitinib and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image